RLS assessment and sleep questionnaires in practice – Lessons learned from Parkinson’s disease

Fahn, 1987, Unified Parkinson’s Disease Rating Scale, 153 Walters, 2003, Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome, Sleep Med, 4, 121, 10.1016/S1389-9457(02)00258-7 Allen, 2003, Factor analysis of the International Restless Legs Syndrome Study Group’s scale for restless legs severity, Sleep Med, 4, 133, 10.1016/S1389-9457(02)00193-4 Kohnen, 2002, Development of the disease-specific Restless Legs Syndrome Quality of Life (RLS-QoL) questionnaire, Mov Disord, 17, A232 Högl, 2005, Restless legs syndrome: a community-based study of prevalence, severity, and risk factors, Neurology, 64, 1920, 10.1212/01.WNL.0000163996.64461.A3 Tison, 2005, Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT Study, Neurology, 65, 239, 10.1212/01.wnl.0000168910.48309.4a Hening, 2004, Subjective and objective criteria in the diagnosis of the restless legs syndrome, Sleep Med, 5, 285, 10.1016/j.sleep.2004.01.006 Kohnen, 2003, Severity rating of restless legs syndrome: review of ten years experience with the RLS-6 scales in clinical trials, Sleep, 26, A342 Kohnen, 2004, Severity Rating of Restless Legs Syndrome: validation of RLS-6 Scales, Sleep, 27, A304 Allen, 2001, Validation of the Johns Hopkins restless legs severity scale, Sleep Med, 2, 239, 10.1016/S1389-9457(00)00080-0 Högl, 2005, Clinical global impression-improvement (CGI-I) and patient global improvement (PGI) are equivalent and useful tools in measuring treatment effects in restless legs syndrome (RLS) patients, Eur J Neurol, 12, 215 Oertel, 2005, Pramipexole is effective in the treatment of restless legs syndrome (RLS): results of a 6 week, multi-centre, double-blind, and placebo-controlled study, Mov Disord, 20, S58 Oertel, 2005, Early and persistent effect of pramipexole in restless legs syndrome (RLS) patients already with the starting dose, Mov Disord, 20, S58 Benes, 2004, A new approach to improve the reliability and validity of RLS diagnoses: the restless legs syndrome diagnostic index (RLS-DI), Mov Disord, 19, S419 Benes, 2005, Validation of an algorithm for the diagnosis of the restless legs syndrome (RLS): the restless legs syndrome diagnostic index (RLS-DI), Sleep, 28, A274 Allen, 2003, Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health, Sleep Med, 4, 101, 10.1016/S1389-9457(03)00010-8 Garcia-Borreguero D, Högl B, Ferini-Strambi L, et al. Validation of the Augmentation Severity Rating Scale (ASRS); a multicentric prospective study with levodopa on restless legs syndrome. Sleep Med 2007, (in press). Garcia-Borreguero, 2005, Augmentation during Long-Term Treatment with l-DOPA in Restless Legs Syndrome: results of a Multicentric Study in Europe, Sleep, 28, A272 Högl, 2005, On the development of the, Structured Interview for Diagnosis of Augmentation during RLS treatment (RLS-SIDA): first experiences, Sleep Med, 6, S158 Abetz, 2005, Validation of the Restless Legs Syndrome Quality of Life questionnaire, Value Health, 8, 157, 10.1111/j.1524-4733.2005.03010.x Abetz, 2005, The reliability, validity and responsiveness of the Restless Legs Syndrome Quality of Life questionnaire (RLSQoL) in a trial population, Health Qual Life Outcomes, 3, 79, 10.1186/1477-7525-3-79 Atkinson, 2004, Validation of the Restless Legs Syndrome Quality of Life Instrument (RLS-QLI): findings of a consortium of national experts and the RLS Foundation, Qual Life Res, 13, 679, 10.1023/B:QURE.0000021322.22011.d0 Ware, 1992, The MOS 36-item short-form health survey (SF-36).I. Conceptual framework and item selection, Med Care, 30, 473, 10.1097/00005650-199206000-00002 Abetz, 2004, Evaluating the quality of life of patients with restless legs syndrome, Clin Ther, 26, 925, 10.1016/S0149-2918(04)90136-1 Allen, 2005, Restless legs syndrome prevalence and impact: REST general population study, Arch Intern Med, 165, 1286, 10.1001/archinte.165.11.1286 Goetz, 2007, Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): process, format and clinimetric testing plan, Mov Disord, 22, 41, 10.1002/mds.21198 Martinez-Martin, 1994, Unified Parkinson’s Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group, Mov Disord, 9, 76, 10.1002/mds.870090112 Richards, 1994, Interrater reliability of the Unified Parkinson’s Disease Rating Scale motor examination, Mov Disord, 9, 89, 10.1002/mds.870090114 Bennett, 1997, Metric properties of nurses’ ratings of parkinsonian signs with a modified Unified Parkinson’s Disease Rating Scale, Neurology, 49, 1580, 10.1212/WNL.49.6.1580 Van Hilten, 1994, Rating impairment and disability in Parkinson’s disease: evaluation of the Unified Parkinson’s Disease Rating Scale, Mov Disord, 9, 84, 10.1002/mds.870090113 Post, 2005, Unified Parkinson’s disease rating scale motor examination: are ratings of nurses, residents in neurology, and movement disorders specialists interchangeable?, Mov Disord, 20, 1577, 10.1002/mds.20640